122 related articles for article (PubMed ID: 24470460)
21. Renal sympathetic denervation for resistant hypertension in a child after aortic coarctation surgery.
Buchhorn R; Ziemer G; Jetter HM; M Borst M; Selbach J
Int J Cardiol; 2014 Apr; 172(3):e447-8. PubMed ID: 24491868
[No Abstract] [Full Text] [Related]
22. SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.
Tsioufis C; Dimitriadis K; Papademetriou V; Tousoulis D
Hellenic J Cardiol; 2017; 58(5):320-321. PubMed ID: 29056558
[No Abstract] [Full Text] [Related]
23. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.
Tuzcu ZB; Asicioglu E; Sunbul M; Ozben B; Arikan H; Koc M
Am J Obstet Gynecol; 2015 Oct; 213(4):533.e1-7. PubMed ID: 26116870
[TBL] [Abstract][Full Text] [Related]
24. Renal denervation for human hypertension: is there a future?
Izzo JL; Tobe SW
J Am Soc Hypertens; 2016 May; 10(5):390-2. PubMed ID: 27049792
[TBL] [Abstract][Full Text] [Related]
25. [Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure].
Rundqvist B; Völz S; Manhem K; Herlitz H; Haraldsson I; Andersson B
Lakartidningen; 2013 Jan 16-22; 110(3):86-8. PubMed ID: 23424985
[No Abstract] [Full Text] [Related]
26. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
[No Abstract] [Full Text] [Related]
27. Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia.
Hilbert S; Rogge C; Papageorgiou P; Hindricks G; Bollmann A
Clin Res Cardiol; 2015 Mar; 104(3):279-81. PubMed ID: 25384356
[No Abstract] [Full Text] [Related]
28. Encouraging Results of Renal Denervation in Resistant Hypertension Patients With Obstructive Sleep Apnea.
Kumagai H; Oshima N
Circ J; 2016 May; 80(6):1316-8. PubMed ID: 27170201
[No Abstract] [Full Text] [Related]
29. [Impact of renal denervation on expression of renalase and tyrosine hydroxylase in adult rats with spontaneous hypertension].
Guo Y; Li L; Tan L; Tang X; Yang Q; Jiang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):829-33. PubMed ID: 22954924
[TBL] [Abstract][Full Text] [Related]
30. Pushing the boundaries of renal denervation for resistant hypertension.
Bhatt DL
Catheter Cardiovasc Interv; 2013 Feb; 81(2):340-1. PubMed ID: 23423926
[No Abstract] [Full Text] [Related]
31. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
Esler M
J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
[TBL] [Abstract][Full Text] [Related]
32. Resistant hypertension: multivariate predictors of blood pressure response to renal denervation.
Prochnau D; Heymel S; Göbel B; Figulla HR; Surber R
Int J Cardiol; 2013 Oct; 168(3):3130-2. PubMed ID: 23659880
[No Abstract] [Full Text] [Related]
33. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
34. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
[TBL] [Abstract][Full Text] [Related]
35. [Renal denervation - a novel therapeutic option for resistant hypertension?].
Ritter A; Sudano Noll I; Suter PM
Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
[No Abstract] [Full Text] [Related]
36. [Renal denervation: long-term Swiss experiences].
Sudano I; Battegay E; Erne P; Lüscher TF
Praxis (Bern 1994); 2015 Jan; 104(1):27-31. PubMed ID: 25552444
[TBL] [Abstract][Full Text] [Related]
37. Renal denervation attenuates NADPH oxidase-mediated oxidative stress and hypertension in rats with hydronephrosis.
Peleli M; Al-Mashhadi A; Yang T; Larsson E; Wåhlin N; Jensen BL; G Persson AE; Carlström M
Am J Physiol Renal Physiol; 2016 Jan; 310(1):F43-56. PubMed ID: 26538440
[TBL] [Abstract][Full Text] [Related]
38. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.
Savard S; Frank M; Bobrie G; Plouin PF; Sapoval M; Azizi M
J Am Coll Cardiol; 2012 Dec; 60(23):2422-4. PubMed ID: 23141491
[No Abstract] [Full Text] [Related]
39. Single-sided renal denervation may be not suitable for patients with significant renal artery stenosis.
Wang Y
Clin Res Cardiol; 2014 Nov; 103(11):950-1. PubMed ID: 25049049
[No Abstract] [Full Text] [Related]
40. CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1: biomarkers in search of validation in lymphomas.
Martin P
Leuk Lymphoma; 2012 Jan; 53(1):1-2. PubMed ID: 22035419
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
